VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > hmm...spending money they don't have

<< Previous

Bullboard Posts

Next >>

Comment by jopatcloon Sep 11, 2024 3:26pm

30 Views

Post# 36219100

RE:RE:RE:hmm...spending money they don't have

now 0.18$ on TSX-V

15:13 R 0,18 0,03 0,175 0,18 9 500 / 13 500 153,81k 0,18 0,155

With FDA V4.0 approved will be among the biggest in healthcare. Very interesting Sponsors Ventripoint The next European Echocardiography Course will be held in Copenhagen from September 11th – 13th 2024.andhttps://www.echocardiography-course.com/ and GEHealthCare,PHILIPS,CANON MEDICALE,AI BODY Hoping to meet all interested colleagues on the next Course. With kind regards, Jan Marek, Folkert Meijboom and Luc Mertens